tiprankstipranks
Trending News
More News >
Positive Outlook for Tandem Diabetes Care with Strong Recovery and Growth Opportunities
PremiumRatingsPositive Outlook for Tandem Diabetes Care with Strong Recovery and Growth Opportunities
22d ago
Tandem Diabetes Care Reports Record Sales and Strategic Growth
Premium
Company Announcements
Tandem Diabetes Care Reports Record Sales and Strategic Growth
22d ago
Tandem Diabetes price target lowered to $24 from $33 at Baird
Premium
The Fly
Tandem Diabetes price target lowered to $24 from $33 at Baird
23d ago
Tandem Diabetes Care: Strong Q1 Performance Amid Cautious Outlook and Hold Rating
PremiumRatingsTandem Diabetes Care: Strong Q1 Performance Amid Cautious Outlook and Hold Rating
23d ago
Tandem Diabetes Care Reports Record Q1 Sales Growth
Premium
Company Announcements
Tandem Diabetes Care Reports Record Q1 Sales Growth
23d ago
Tandem Diabetes Care’s Strong Q1 Performance and Growth Drive Buy Rating
Premium
Ratings
Tandem Diabetes Care’s Strong Q1 Performance and Growth Drive Buy Rating
23d ago
Tandem Diabetes price target lowered to $45 from $55 at RBC Capital
PremiumThe FlyTandem Diabetes price target lowered to $45 from $55 at RBC Capital
1M ago
Hold Rating for Tandem Diabetes Care Amid Competitive and Macroeconomic Challenges
Premium
Ratings
Hold Rating for Tandem Diabetes Care Amid Competitive and Macroeconomic Challenges
1M ago
Tandem Diabetes initiated with a Neutral at Mizuho
Premium
The Fly
Tandem Diabetes initiated with a Neutral at Mizuho
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100